Breast Cancer
Conference Coverage
Developing Community Partnerships to Improve Breast Cancer Survivorship for Young Women
News
Pyrotinib bests lapatinib in HER2+ metastatic breast cancer treatment
The pan-ErbB inhibitor pyrotinib plus capecitabine had manageable toxicity, a significantly higher ORR, and significantly longer PFS, compared...
News
USPSTF recommends preventive breast cancer medications only for women at risk
The USPSTF finds minimal value in medications to help prevent breast cancer for women not at increased risk
News
Protons safe, effective for breast cancer control
Toxicity and disease control rates with proton-beam therapy to treat internal mammary nodes compared favorably with those of conventional...
News
Neratinib in combo with T-DM1 shows promise for advanced HER2+ breast cancer
Responses were most durable in patients with cell-free DNA ERBB2 amplification.
News
Oncologists agree with AI treatment decisions about half the time
In the first study of its kind, involving 10 Chinese oncologists and 1,977 patients with complex breast cancer, treatment recommendations from the...
News
Cancer survivors face more age-related deficits
Cancer survivors are more likely to experience age-related health deficits and increased mortality, compared with people without a history of...
News
Diet, exercise don’t improve breast cancer-related lymphedema
There were no significant differences in limb volume changes among overweight women with lymphedema 1 year after starting a lifestyle intervention...
News
Recurrence score may help predict chemotherapy benefit in grade 3 breast cancers
In data that complement the TAILORx findings, chemotherapy was not linked with significantly improved OS for those with a low recurrence score...
News
USPSTF expands BRCA1/2 testing recommendations
Personal cancer history, ancestry now key factors in decision to assess, counsel, and test for potentially harmful mutations in BRCA1/2 genes.